Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 credit™.

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by PERT Consortium.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

 

Objectives

At the conclusion of this activity, the participants will be able to:

  1. Discuss the epidemiology and pathophysiology of PE, including how to assess the risk of patients presenting with symptoms consistent with PE.
  2. Identify features that define low-, intermediate- and high-risk PE.
  3. Develop a diagnostic and treatment algorithm that incorporates risk stratification and meets the specific needs of patients presenting with signs and symptoms of PE.
  4. Appropriately select among various treatment options for intermediate- and high-risk PE patients including: anticoagulation, fibrinolysis (intravenous and catheter-directed), extra-corporeal membrane oxygenation (ECMO), thrombectomy (suction and surgical), and IVC filter placement.
  5. Recognize the potential acute and long-term complications of PE and how to prevent and treat them.
  6. Describe unique patient populations with PE and their specific treatment challenges
  7. Discuss the benefits of a multidisciplinary approach to PE management, and how to implement a PE Response Team (PERT) in their hospital.
  8. Identify what constitutes high quality care for PE.
  9. Target opportunities for quality improvement in their institution.

 

Target Audience

This two day course is designed to educate practicing clinicians who diagnose and/or treat patients with pulmonary embolism; academics and scientists who study pulmonary embolism.

 

Faculty Disclosure

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.